Platelet mitochondrial membrane depolarization reflects disease severity in patients with sepsis and correlates with clinical outcome

Critical Care

Volumn 18, Issue 1, 2014, Pages

  Gründler, Katharina ^a   Angstwurm, Matthias ^a   Hilge, Robert ^a   Baumann, Philipp ^a   Annecke, Thorsten ^a   Crispin, Alexander ^b   Sohn, Hae Young ^a   Massberg, Steffen ^a   Kraemer, Bjoern F ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL XL;

ADULT; AGED; APACHE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; MALE; MEMBRANE DEPOLARIZATION; MIDDLE AGED; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; ORGAN DYSFUNCTION SCORE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; SIMPLIFIED ACUTE PHYSIOLOGY SCORE; SURVIVOR; THROMBOCYTE; CASE CONTROL STUDY; CLASSIFICATION; INTENSIVE CARE UNIT; MORTALITY; MULTIPLE ORGAN FAILURE; PHYSIOLOGY; PROCEDURES; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; APACHE; BLOOD PLATELETS; CASE-CONTROL STUDIES; FEMALE; FLOW CYTOMETRY; HUMANS; INTENSIVE CARE UNITS; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PROGNOSIS; SEPSIS; SEVERITY OF ILLNESS INDEX;

EID: 84896777468     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13724     Document Type: Article

References (44)

1. Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care 2010, 14:R15. 10.1186/cc8872, 2875530, 20144219.
2. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829. 10.1097/00003246-198510000-00009, 3928249.
3. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270:2957-2963. 10.1001/jama.1993.03510240069035, 8254858.
4. Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study: Working Group on " sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 1998, 26:1793-1800. 10.1097/00003246-199811000-00016, 9824069.
5. Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 2013, 13:34-45.
6. Kraemer BF, Campbell RA, Schwertz H, Cody MJ, Franks Z, Tolley ND, Kahr WH, Lindemann S, Seizer P, Yost CC, Zimmerman GA, Weyrich AS, et al. Novel anti-bacterial activities of beta-defense 1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation. PLoS Pathog 2011, 7:e1002355. 10.1371/journal.ppat.1002355, 3213094, 22102811.
7. Semple JW, Freedman J. Platelets and innate immunity. Cell Mol Life Sci 2010, 67:499-511. 10.1007/s00018-009-0205-1, 20016997.
8. Weyrich AS, Zimmerman GA. Platelets: signaling cells in the immune continuum. Trends Immunol 2004, 25:489-495. 10.1016/j.it.2004.07.003, 15324742.
9. Gafter-Gvili A, Mansur N, Bivas A, Zemer-Wassercug N, Bishara J, Leibovici L, Paul M. Thrombocytopenia in Staphylococcus aureus bacteremia: risk factors and prognostic importance. Mayo Clin Proc 2011, 86:389-396. 10.4065/mcp.2010.0705, 3084641, 21531882.
10. Vandijck DM, Blot SI, De Waele JJ, Hoste EA, Vandewoude KH, Decruyenaere JM. Thrombocytopenia and outcome in critically ill patients with bloodstream infection. Heart Lung 2010, 39:21-26. 10.1016/j.hrtlng.2009.07.005, 20109983.
11. Akca S, Haji-Michael P, de Mendonca A, Suter P, Levi M, Vincent JL. Time course of platelet counts in critically ill patients. Crit Care Med 2002, 30:753-756. 10.1097/00003246-200204000-00005, 11940740.
12. Strauss R, Wehler M, Mehler K, Kreutzer D, Koebnick C, Hahn EG. Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med 2002, 30:1765-1771. 10.1097/00003246-200208000-00015, 12163790.
13. Couto-Alves A, Wright VJ, Perumal K, Binder A, Carrol ED, Emonts M, de Groot R, Hazelzet J, Kuijpers T, Nadel S, Zenz W, Ramnarayan P, Levin M, Coin L, Inwald DP, et al. A new scoring system derived from base excess and platelet count at presentation predicts mortality in paediatric meningococcal sepsis. Crit Care 2013, 17:R68. 10.1186/cc12609, 3672696, 23577792.
14. Bozza FA, Shah AM, Weyrich AS, Zimmerman GA. Amicus or adversary: platelets in lung biology, acute injury, and inflammation. Am J Respir Cell Mol Biol 2009, 40:123-134. 10.1165/rcmb.2008-0241TR, 2633137, 18723438.
15. Kraemer BF, Campbell RA, Schwertz H, Franks ZG, Vieira de Abreu A, Grundler K, Kile BT, Dhakal BK, Rondina MT, Kahr WH, Mulvey MA, Blaylock RC, Zimmerman GA, Weyrich AS, et al. Bacteria differentially induce degradation of Bcl-xL, a survival protein, by human platelets. Blood 2012, 120:5014-5020. 10.1182/blood-2012-04-420661, 3525025, 23086749.
16. Garrabou G, Moren C, Lopez S, Tobias E, Cardellach F, Miro O, Casademont J. The effects of sepsis on mitochondria. J Infect Dis 2012, 205:392-400. 10.1093/infdis/jir764, 22180620.
17. Harrois A, Huet O, Duranteau J. Alterations of mitochondrial function in sepsis and critical illness. Curr Opin Anaesthesiol 2009, 22:143-149. 10.1097/ACO.0b013e328328d1cc, 19390243.
18. Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R, Davies NA, Cooper CE, Singer M. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002, 360:219-223. 10.1016/S0140-6736(02)09459-X, 12133657.
19. Rudiger A, Singer M. Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med 2007, 35:1599-1608. 10.1097/01.CCM.0000266683.64081.02, 17452940.
20. Adrie C, Bachelet M, Vayssier-Taussat M, Russo-Marie F, Bouchaert I, Adib-Conquy M, Cavaillon JM, Pinsky MR, Dhainaut JF, Polla BS. Mitochondrial membrane potential and apoptosis peripheral blood monocytes in severe human sepsis. Am J Respir Crit Care Med 2001, 164:389-395. 10.1164/ajrccm.164.3.2009088, 11500338.
21. Lorente L, Iceta R, Martin MM, Lopez-Gallardo E, Sole-Violan J, Blanquer J, Labarta L, Diaz C, Jimenez A, Montoya J, Ruiz-Pesini E, et al. Survival and mitochondrial function in septic patients according to mitochondrial DNA haplogroup. Crit Care 2012, 16:R10. 10.1186/cc11150, 3396241, 22251664.
22. Lorente L, Martin MM, Lopez-Gallardo E, Iceta R, Sole-Violan J, Blanquer J, Labarta L, Diaz C, Jimenez A, Lafuente N, Hernandez M, Mendez F, Medina N, Ferrer-Agüero JM, Ferreres J, Lliminana MC, Mora ML, Lubillo S, Sanchez-Palacios M, Montoya J, Ruiz-Pedini E, et al. Platelet cytochrome c oxidase activity and quantity in septic patients. Crit Care Med 2011, 39:1289-1294. 10.1097/CCM.0b013e31820ee20c, 21297457.
23. Sjovall F, Morota S, Hansson MJ, Friberg H, Gnaiger E, Elmer E. Temporal increase of platelet mitochondrial respiration is negatively associated with clinical outcome in patients with sepsis. Crit Care 2010, 14:R214. 10.1186/cc9337, 3219983, 21106065.
24. Yamakawa K, Ogura H, Koh T, Ogawa Y, Matsumoto N, Kuwagata Y, Shimazu T. Platelet mitochondrial membrane potential correlates with severity in patients with systemic inflammatory response syndrome. J Trauma Acute Care Surg 2013, 74:411-417. discussion 418, 10.1097/TA.0b013e31827a34cf, 23354232.
25. Kile BT. The role of the intrinsic apoptosis pathway in platelet life and death. J Thromb Haemost 2009, 7:214-217.
26. Mason KD, Carpinelli MR, Fletcher JI, Collinge JE, Hilton AA, Ellis S, Kelly PN, Ekert PG, Metcalf D, Roberts AW, Huang DC, Kile BT, et al. Programmed anuclear cell death delimits platelet life span. Cell 2007, 128:1173-1186. 10.1016/j.cell.2007.01.037, 17382885.
27. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: The ACCP/SCCM Consensus Conference Committee, American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655. 10.1378/chest.101.6.1644, 1303622.
28. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31:1250-1256. 10.1097/01.CCM.0000050454.01978.3B, 12682500.
29. Ceriani R, Mazzoni M, Bortone F, Gandini S, Solinas C, Susini G, Parodi O. Application of the sequential organ failure assessment score to cardiac surgical patients. Chest 2003, 123:1229-1239. 10.1378/chest.123.4.1229, 12684316.
30. Ulvik A, Kvale R, Wentzel-Larsen T, Flaatten H. Multiple organ failure after trauma affects even long-term survival and functional status. Crit Care 2007, 11:R95. 10.1186/cc6111, 2556737, 17784940.
31. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure, on behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710. 10.1007/BF01709751, 8844239.
32. Verhoeven AJ, Verhaar R, Gouwerok EG, de Korte D. The mitochondrial membrane potential in human platelets: a sensitive parameter for platelet quality. Transfusion 2005, 45:82-89. 10.1111/j.1537-2995.2005.04023.x, 15647022.
33. Leytin V, Allen DJ, Mutlu A, Gyulkhandanyan AV, Mykhaylov S, Freedman J. Mitochondrial control of platelet apoptosis: effect of cyclosporin A, an inhibitor of the mitochondrial permeability transition pore. Lab Invest 2009, 89:374-384. 10.1038/labinvest.2009.13, 19238135.
34. Yaguchi A, Lobo FL, Vincent JL, Pradier O. Platelet function in sepsis. J Thromb Haemost 2004, 2:2096-2102. 10.1111/j.1538-7836.2004.01009.x, 15613012.
35. Azevedo LC, Janiszewski M, Pontieri V, de Pedro M A, Bassi E, Tucci PJ, Laurindo FR. Platelet-derived exosomes from septic shock patients induce myocardial dysfunction. Crit Care 2007, 11:R120. 10.1186/cc6176, 2246209, 17996049.
36. Rondina MT, Schwertz H, Harris ES, Kraemer BF, Campbell RA, Mackman N, Grissom CK, Weyrich AS, Zimmerman GA. The septic milieu triggers expression of spliced tissue factor mRNA in human platelets. J Thromb Haemost 2011, 9:748-758. 10.1111/j.1538-7836.2011.04208.x, 3071458, 21255247.
37. Yeaman MR, Bayer AS, Koo SP, Foss W, Sullam PM. Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action. J Clin Invest 1998, 101:178-187. 10.1172/JCI562, 508554, 9421480.
38. Yeaman MR, Sullam PM, Dazin PF, Bayer AS. Platelet microbicidal protein alone and in combination with antibiotics reduces Staphylococcus aureus adherence to platelets in vitro. Infect Immun 1994, 62:3416-3423. 302973, 8039912.
39. Kroemer G. Mitochondrial control of apoptosis: an introduction. Biochem Biophys Res Commun 2003, 304:433-435. 10.1016/S0006-291X(03)00614-4, 12729576.
40. Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssiere JL, Petit PX, Kroemer G. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med 1995, 181:1661-1672. 10.1084/jem.181.5.1661, 2192017, 7722446.
41. Fink MP. Cytopathic hypoxia: mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. Crit Care Clin 2001, 17:219-237. 10.1016/S0749-0704(05)70161-5, 11219231.
42. Ince C. The microcirculation is the motor of sepsis. Crit Care 2005, 9:S13-S19. 10.1186/cc3753, 3226164, 16168069.
43. Hotchkiss RS, Swanson PE, Knudson CM, Chang KC, Cobb JP, Osborne DF, Zollner KM, Buchman TG, Korsmeyer SJ, Karl IE. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J Immunol 1999, 162:4148-4156.
44. Towhid ST, Nega M, Schmidt EM, Schmid E, Albrecht T, Munzer P, Borst O, Gotz F, Lang F. Stimulation of platelet apoptosis by peptidoglycan from Staphylococcus aureus 113. Apoptosis 2012, 17:998-1008. 10.1007/s10495-012-0718-1, 22752708.